Keyword: London

FundamentalVR launched a virtual surgery platform that uses physical feedback to create a tactile, flight simulator-like experience for surgeons.

Sensyne Health plans to go public with a £60 million listing ($77 million) on the London Stock Exchange on Aug. 17.

An AI startup raised $1 million to develop “machine reading” programs to digest and distill published biomedical literature and research.

Endoscopic device maker Creo has been considering additional funding, following FDA clearance of its tool for removing colorectal polyps.

The European Medicines Agency has begun laying the foundation for its new Amsterdam headquarters, aiming to finish construction by November 2019.

The U.K. will endeavor to keep pace with the European Union’s impending changes in clinical trial procedures post-Brexit.

Polarean, a North Carolina-based devicemaker focused on the MRI market, said it plans to raise as much as $4.3 million in a public offering listing.

British-based oncology R&D charity Cancer Research UK will inject £45 million ($63 million) across its clinical trial network in the U.K.

ReViral has hit its primary and secondary endpoints in a small midstage trial testing its experimental med against RSV.

The precipitous drop in the amount of space available to the EMA will force the agency to hold meetings off-site.